Cargando…
Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
Aberrant activation of nuclear factor kappa B (NF-κB) has been linked with the pathogenesis of several proinflammatory diseases including number of cancers and inflammatory bowel diseases. In the present work, we evaluated the anticancer activity of 1,2-oxazines derivatives against colorectal cancer...
Autores principales: | Nirvanappa, Anilkumar C., Mohan, Chakrabhavi Dhananjaya, Rangappa, Shobith, Ananda, Hanumappa, Sukhorukov, Alexey Yu, Shanmugam, Muthu K., Sundaram, Mahalingam S., Nayaka, Siddaiah Chandra, Girish, Kesturu S., Chinnathambi, Arunachalam, Zayed, M. E., Alharbi, Sulaiman Ali, Sethi, Gautam, Basappa, Rangappa, Kanchugarakoppal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042377/ https://www.ncbi.nlm.nih.gov/pubmed/27685808 http://dx.doi.org/10.1371/journal.pone.0163209 |
Ejemplares similares
-
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
por: Nirvanappa, Anilkumar C., et al.
Publicado: (2017) -
A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A(2)
por: Anilkumar, Nirvanappa C., et al.
Publicado: (2015) -
Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
por: Somu, Chaithanya, et al.
Publicado: (2020) -
Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018) -
Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
por: Baburajeev, C. P., et al.
Publicado: (2015)